Evidence map›Paper›PMID 31057504›Full record

ArticleFrontiers in microbiology2019

Validation of a 16th Century Traditional Chinese Medicine Use of

François Chassagne, Xinyi Huang, James T Lyles, Cassandra L Quave

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. TiOAdvances in neurobiology · 2023
    Review
  7. Review
  8. Therapeutic Versus Preventative Use ofMolecules (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Cytotoxic effect ofHeliyon · 2020
    Article
  16. Natural Compounds from the Marine Brown AlgaPathogens (Basel, Switzerland) · 2020
    Article
  17. Article
  18. Exploring the Anti-Acne Potential of Impepho [Frontiers in pharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

François ChassagneCenter for the Study of Human Health, Emory University, Atlanta, GA, United States.
Xinyi HuangCenter for the Study of Human Health, Emory University, Atlanta, GA, United States.
James T LylesCenter for the Study of Human Health, Emory University, Atlanta, GA, United States.
Cassandra L QuaveCenter for the Study of Human Health, Emory University, Atlanta, GA, United States.

Funding

Novel compounds from botanical innovation yields Acinetobacter treatmentsR21AI136563 · NIAID · EMORY UNIVERSITY · PI QUAVE, CASSANDRA LEAH · 2018 to 2019
$443k
Activity-Aware Prompting to Improve Medication Adherence in Heart Failure PatientsR21NR015410 · NINR · WASHINGTON STATE UNIVERSITY · PI COOK, DIANE JOYCE, EVANGELISTA, LORRAINE S · 2016 to 2017
$375k
NIAID NIH HHS R21 AI136563NINR NIH HHS R21 NR015410
6 · The paper itself

Abstract

In the search for new therapeutic solutions to address an increasing number of multidrug-resistant bacterial pathogens, secondary metabolites from plants have proven to be a rich source of antimicrobial compounds.

Indexed as

ESKAPEGinkgoginkgolic acidskin infectionsTCM

Identifiers

PMID31057504
PMCPMC6478001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.